The
5th Due Diligence Summit for Life Sciences, taking place on May 15-16, 2018 in Boston, MA, is the industry's leading cross-functional life science event focused on the needs of due diligence professionals. This conference will highlight the latest M&A trends in the market, educate due diligence professionals on the different aspects and challenges faced by cross-functional team members, and provide attendees with the strategies and insight they need to effectively conduct thorough
due diligence to ensure a profitable investment in a new product, portfolio, company or strategic alliance.
Over the last four years, this summit has provided due diligence professionals with a platform to explore innovative models and deal structures for collaborating with strategic partners, and discussed valuable strategies for conducting efficient and effective
due diligence. Join your peers at the
5th Due Diligence Summit for Life Sciences for the opportunity to network and engage with some of the industry's leading experts.
Top Five Reasons to Attend
- Explore best practices for companies of all sizes looking to acquire or in-license a product
- Understand how to conduct a comprehensive intellectual property due diligence investigation, and how it can alter the strategy for your deal
- Learn how to evaluate and effectively manage strategic alliances through case studies from industry leaders
- Assess the regulatory and compliance standards of a target and how gaps can lead to unforeseen financial burdens
- Gain valuable insight on the impact company culture can have on the success of integrating the workforce post-merger or acquisition
Who Should Attend
This conference is designed for representatives
from pharmaceutical, medical device and biotechnology companies with
responsibilities in the following areas:
- Due Diligence
- Business Development
- Strategic Alliance/Alliance Management
- Mergers and Acquisitions
- Licensing
- Intellectual Property and Patent Counsel
- Search and Evaluation
- Portfolio Management
- Scientific Assessment
- General Counsel/Corporate Counsel
- Legal and Regulatory Compliance
- Regulatory Affairs
- Research and Development
- Clinical Medicine
- Clinical Operations
- Life Cycle Management
This conference is also of interest to:
- Investment Banks
- Private Equity Firms
- Venture Capitalists
- Data Room Providers
- Due Diligence Consultants
- Law Firms
- Clinical Affairs and CRO Partners
- Regulatory Affairs and Compliance Partners
Speakers
- Catherine Abbadie, Ph.D., Senior Director, Search, Evaluation and Alliance Management, Corporate Development and Licensing, SUNOVION PHARMACEUTICALS
- John Adamou, Vice President, Corporate and Business Development, RHEALTH
- Marc S. Ballas, Medical Director, R&D, GLAXOSMITHKLINE
- Alex Chang, Ph.D., Executive Director, Business Development, HELSINN THERAPEUTICS (U.S.)
- Mike DeRidder, Global Head Oncology Cell Therapy Commercial Strategy, GLAXOSMITHKLINE
- Teresa Faria, Ph.D., Senior Director, Alliance Management, External Scientific Affairs, DAIICHI SANKYO
- Rebecca Holland New, Group Vice President, Global Business Management, THERMO FISHER SCIENTIFIC
- Rick Hoyt, Vice President, Business Development and Licensing, MALLINCKRODT
- Orly Mishan, Principal, BAIN CAPITAL LIFE SCIENCE
- Mike Myers, Senior Director, Lilly Research Labs - Due Diligence, ELI LILLY
- Paul Nitschmann, Executive Director, Regulatory Therapeutic Area Head, Cardiovascular, CNS, Bone, AMGEN
- Brad Payne, MBA, Vice President, ARTISAN HEALTHCARE CONSULTING
- Martin Picard, Ph.D., Vice President, Global Head Search, Evaluation and Due Diligence, MERCK KGAA
- Walter Sandulli, MBA, Vice President, Business Development and Licensing (M&A), AKRIMAX PHARMACEUTICALS
- Marc Schwabish, Ph.D., Senior Vice President, Business Development and U.S. Operations, FUSION PHARMACEUTICALS
- Rachel Sha, Head, Digital Business Development and Licensing, SANOFI
- Shanker Shrestha, Head of Customer Success (U.S.), INOVA SOFTWARE
- Scott Simmons, Consultant, External Innovation – Due Diligence, ELI LILLY AND COMPANY
Please fill in your name and email to receive the conference agenda of this event.
Conference Day One - Tuesday, May 15, 2018
Conference Day Two - Wednesday, May 16, 2018
The agenda is available as PDF under downloads at the right side of the page.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
Venue
Hilton Boston Logan AirportOne Hotel Drive
Boston, MA 02128
Hilton Boston Logan Airport is the only hotel on airport property directly connected to Terminals A and E via pedestrian walkways. Close to downtown Boston, our hotel is just 10 minutes from the Boston Convention & Exhibition Center and Seaport World Trade Center.
To make reservations, please call 1-800-HILTONS and request the negotiated rate for ExL’s 5th Due Diligence Summit. To make reservations online, please
click hereThe group rate is available until April 24, 2018. Please book your room early, as rooms available at this rate are limited.
